Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-002601
Filing Date
2013-01-09
Accepted
2013-01-09 15:06:54
Documents
1
Period of Report
2013-01-07

Document Format Files

Seq Description Document Type Size
1 rrd366444.html 4  
1 rrd366444.xml 4 3825
  Complete submission text file 0001181431-13-002601.txt   5260
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
Nunn Jason Raleigh (Reporting) CIK: 0001444319 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 13520417